Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia.
about
Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on AsparaginaseAugmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.Outcomes for children and adolescents with cancer: challenges for the twenty-first century.Blood consult: therapeutic strategy and complications in the adolescent and young adult with acute lymphoblastic leukemiaCancer survival and excess mortality estimates among adolescents and young adults in Western Australia, 1982-2004: a population-based studyYoung adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.Immunophenotype and increased presence of CD4(+)CD25(+) regulatory T cells in patients with acute lymphoblastic leukemiaAdvances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the ClinicWhat determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studiesSuccessful management of multifactorial colitis in a recipient of hematopoietic stem cell transplant: a case report.Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohortsImpact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia.Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.Genomic profiling of high-risk acute lymphoblastic leukemia.Improving outcomes for high-risk ALL: translating new discoveries into clinical care.Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia.Pediatric haematopoiesis and related malignancies.The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-FrankReal-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America.Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis.High dose methotrexate treatment in children with acute lymphoblastic leukaemia may be optimised by a weight-based dose calculation.Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.
P2860
Q26784116-5597170A-4706-4314-B329-7458AD1A5D77Q33747668-F9CE2786-E265-4042-B0F8-E0F092467EFCQ33897659-A0BFF1D8-8407-43C3-8F55-4DC79F2FC84FQ34009088-C626B1C8-8B36-4AF2-BE37-B62775E00990Q34584383-4911A3D2-9531-4B51-B70E-BC850CDE9A4AQ34645985-2028D97E-CAAA-467F-A89C-10C5F82DAC45Q35995564-A5335648-29E0-4FDA-B48C-902A844AB352Q36752634-2E8E9640-253B-4C19-9F2A-B3CADDCE05F3Q36843677-C3E555A8-BDB6-4B23-BDFF-487011ABD20AQ37202971-4488F152-4A94-41EF-8D85-F3FC8734D320Q37273171-BF08C8CC-27B2-4516-BE86-47134771F646Q37627410-0C8203DC-05F8-4CCA-B108-41FBAB5B3CEEQ37695157-2C736E6A-6123-4665-8FE1-E1C94D247D25Q37782546-F1E8B3C0-9C19-4C83-B643-429CF6EDD211Q37849259-71C26A5D-DCD5-43B9-B940-057ED6968384Q39194553-9D7A4E6F-AF10-409A-AD9D-629292084EE6Q39425967-42C3D1DE-93E8-4EB6-9FE6-55414B5D0BCDQ40097280-E54C8ED3-0298-4FB4-8B98-59C341A9441CQ40427765-D8CD14E5-1099-459E-A192-DF1C6532EA88Q43716583-D3F5EBCB-DD36-42A6-BE90-DDA65CAAE2B4Q47385414-76C47E43-6277-4532-B095-FEF23382C734Q51074196-940F6A0D-92A4-4E82-9F4B-269B682CF6BE
P2860
Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Clinical characteristics, biol ...... acute lymphoblastic leukaemia.
@ast
Clinical characteristics, biol ...... acute lymphoblastic leukaemia.
@en
type
label
Clinical characteristics, biol ...... acute lymphoblastic leukaemia.
@ast
Clinical characteristics, biol ...... acute lymphoblastic leukaemia.
@en
prefLabel
Clinical characteristics, biol ...... acute lymphoblastic leukaemia.
@ast
Clinical characteristics, biol ...... acute lymphoblastic leukaemia.
@en
P2860
P1476
Clinical characteristics, biol ...... acute lymphoblastic leukaemia.
@en
P2093
James Nachman
P2860
P304
P356
10.1111/J.1365-2141.2005.05544.X
P407
P577
2005-07-01T00:00:00Z